The Childhood Trauma Questionnaire (CTQ) was applied to assess childhood trauma, defined as 135 trauma before the age of 16, in five of the nine cohorts (COFAMS, NESDA/NTR, RADIANT UK, SHIP-0, 136 and SHIP-TREND). The CTQ covers the five domains of sexual abuse (SA), physical abuse (PA), 137 emotional abuse (EA), emotional neglect (EN), and physical neglect (PN) . Each domain is assessed by 138 five questions (scored 1 to 5) resulting in a domain score ranging from 5 to 25, and an overall CTQ 139 continuous score ranging from 25 to 125 (36) . Per domain, cutoffs were applied to define a narrow 140 definition of childhood trauma separating no or mild trauma from moderate or severe trauma 141 (Supplemental Methods) . From this, an overall dichotomous CTQ indicator was constructed to 142 separate trauma in any of the five domains (indicator=1) from trauma in none of the domains 143 (indicator=0). The analyses were based on the continuous and dichotomous 5-domain CT scores. The 144 five domains were highly correlated: all pairwise correlation coefficients were larger than 0.4 except 145 for sexual abuse which was slightly less connected (Table S2 ) as has previously also been reported by 146 Spinhoven et al (37) .
148
Other childhood trauma instruments 149 In addition to the five cohorts that assessed childhood trauma with the CTQ instrument, four 150 additional PGC cohorts (DGN and the three sub-cohorts of QIMR) assessed childhood trauma with 151 other instruments (before the age of 18 in QIMR). To obtain the largest possible dataset, childhood 152 trauma information was matched across all nine cohorts for sexual abuse and physical abuse 153 (Supplemental Methods). A broad definition (no abuse versus mild, moderate or severe abuse) was 154 applied to create a childhood trauma indicator separating those with trauma (exposed to sexual 155 and/or physical abuse) from those not exposed to childhood trauma (neither exposed to sexual nor 156 physical abuse). The correlation (Spearman's rho) between the 2-domain dichotomous CT indicator M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 7 domain dichotomous CT indicator. Interaction analyses of PRSxCT were corrected for sex, three 203 principal components, PRS, CT, and the interaction-terms of PRS and CT with sex and the principal 204 components in line with Keller's recommendation (48) . With logistic regression, interaction is tested 205 as departure from multiplicativity (combined impact different from the product of the individual 206 effects), but it has been argued that interaction as departure from additivity (combined impact 207 different from the sum of the individual effects) is more meaningful biologically (49) . For testing 208 interaction as departure from additivity, the relative excess risks due to interaction (RERI) were 209 estimated with the coefficients from logistic regression as ݁ ఉ ುೃೄ ାఉ ାఉ ುೃೄೣ − ݁ ఉ ುೃೄ − ݁ ఉ + 1, 210 and their 95% confidence intervals by means of bootstrapping with 10,000 iterations. The impact of 211 the PRS on MDD was further expressed as variation explained on the liability scale, R 2 (50). The PRS 212 and continuous 5-domain CT measure were standardized (i.e. mean of 0 and variance of 1), and the 213 presented ORs can thus be interpreted as increased MDD risk per standard deviation increase in PRS 214 or CT. The analyses were conducted in R (51).
216
Genetic Relationship Matrix (GRM)-based analyses 217 The variance in MDD liability and CT explained by genotyped SNPs (SNP heritability) was assessed 218 with cross product Haseman-Elston regression (52). These analyses were corrected for covariates by 219 calculating the residuals of linear regression of MDD and CT on sex, genotyping batch and 20 220 ancestry informative principal components (PCs). We included 20 PCs, because GRM-based analyses 221 are more sensitive to population stratification than PRS analyses (7) . To test for interaction between 222 CT and genome-wide genetic effects in MDD, the genetic correlation between MDD in unexposed 223 individuals and MDD in exposed individuals can give information about differences in genetic effects 224 (53) . Unfortunately, the current data did not allow for the latter analyses because of limited sample 225 size (e.g. only 389 exposed controls) while analyses had to be corrected for 9 cohorts. The prevalence of CT was estimated at 0.25 based on the 5-domain indicator (Table 1) , and at 0.17 232 for the 2-domain indicator ( Table 3 ). As expected, the prevalence was considerably larger in cases 233 than controls (0.50 vs 0.21 for the 5-domain measure and 0.35 vs 0.14 for the 2-domain measure).
234
This was reflected in an OR for MDD of 3.80 (p=3.0e-6) for the 5- Figure 1 ).
237
The impact of CT on MDD was comparable in men and women, with ORs of 2.18 (males, p=1.1e-4) 238 and 2.74 (females, p=3.6e-5) per standard deviation increase in the continuous 5-domain CT 239 measures ( Table 1) . CT had an impact on MDD risk in all cohorts (Table 1) , and the five CTQ domains 240 all had an impact on MDD risk (Table S4) .
242
Polygenic risk score analyses 243 The MDD-PRS based on all SNPs (inclusion threshold of p<1) had the greatest predictive power, with 244 an OR of 1.34 (p=5.1e-11, R 2 =1.71%) in the 1957 cases and 2002 controls with availability of the 5-245 domain CT measures ( Table 2 ). The SCZ-PRS and BIP-PRS also predicted MDD but to a lesser extent 246 than the MDD-PRS (Table 2) , reflecting the well-described genetic correlation between MDD, BIP 247 and SCZ (7). Because GE-correlation can lead to spurious GxE-results (54), we tested for an 248 association between the MDD-PRS and CT. The MDD-PRS did predict the 5-domain continuous CT 249 measure (beta=0.76, p=0.004 in linear regression), but this was approximated to only reflect a small 250 correlation in terms of the full population of ~0.04 (Table S5) . No interaction between the PRS and 251 the 5-domain continuous CTQ measure was found, with an impact of MDD-PRSxCT on MDD of 252 OR=1.05 (p=0.52; Table 2 ). In addition, no evidence was found for interaction as departure from 253 additivity (RERI=0.83, 95%CI= -0.62 to 18.03). The BIP-PRS and SCZ-PRS showed no evidence for 254 interaction with the 5-domain CT measure.
255
Applying the 2-domain dichotomous CT indicator of sexual or physical abuse allowed 256 inclusion of four additional cohorts in the analyses ( CT measure (Table 2 ) and the 2-domain CT indicator (Table 3 ). Secondary analyses also showed no 291 evidence for interaction in analyses with PRS based on discovery results from schizophrenia and 292 bipolar disorders, in tests for interaction as departure from additivity, in analyses in males and 293 females separately (Table S6) , and in analysis in the five separate domains of CT (Table S7; 294 significance threshold 0.01=0.05/5). Analyses excluding NESDA and RADIANT UK showed no 295 evidence for interaction between the MDD-PRS (p-value threshold 1) and Therefore, it appears that the OR of the interaction-effects are reduced by adding deCODE (29),
306
GenScotland (41, 42), GERA (43), iPsych (29) and UK Biobank (44, 45) to the PRS discovery sample.
307
These discrepancies in interaction results may reflect different study designs in the discovery 308 datasets with application of self-reported depression status in UKB and clinical records in iPsych and 309 GERA, contrasting the semi-structured interviews (such as the SCID, CIDI and MINI) applied in most 310 PGC cohorts (29). However, these discrepancies may also reflect random variation in effects with 311 discovery sample size increasing from ~37,000 to ~110,000. The latter possibility seems more likely 312 since: (1) we observe an increase in the variance explained by the PRS from 0.66% (p=2.8e-5) to 313 1.71% (p=5.1e-11) (Table S8 ), which corresponds with the increase predicted from theory given the 314 increased sample size (55); (2) a genetic correlation of 0.91-0.96 between the PGC wave 2 discovery 315 results and the extended discovery results as estimated with LD-score regression (30); and (3) an 316 overlap of the 95% CI of the interaction-effects based on the PGC discovery sample and the larger 317 discovery sample applied in this paper (Table S8 ). In other words, our results suggest that the 318 additional discovery cohorts (deCODE, GenScotland, GERA, iPsych, and UK Biobank) capture the 319 same genetic information as the PGC cohorts. Therefore, we hypothesize that the previously 320 reported interaction results in NESDA (27) and RADIANT UK (28) were both chance findings. The fact 321 that these findings were both significant in an opposite direction may reflect the statistical 322 vulnerability of interaction testing (48, 54, 56) .
323
A source of spurious interaction effects can be found in gene-environment (GE) correlation 324 as explained for twin analyses by Purcell (54) . Notably, the PRS based on the PGC wave 2 discovery 325 results were slightly more correlated with childhood trauma in the full population (with 326 approximately -0.09 in NESDA and 0.13 in RADIANT UK) than the PRS based on the extended sample 327 (~0.02 and ~0.06 respectively). A simulation study suggested that the type I error rate can indeed be 328 inflated in the context of GE-correlation, but to a modest extent of 0.075 (with alpha set at 0.05) for 329 a strong correlation of 0.3 between G and E (Supplemental Methods). It is, therefore, unlikely that 330 the GxE-interactions previously found would be attributable to GE-correlation.
331
The current study has both strengths and limitations. First, this study is the largest to date to 332 test for interaction between polygenic risk scores and CT in MDD risk. Second, polygenic risk scores 333 were based on a powerful discovery GWAS with approximately 110,000 individuals. Third, diagnoses 334 were DSM-based aiming to select clinically relevant cases of MDD. A limitation of our study is that CT 335 was not assessed uniformly across cohorts for the 2-domain measure, but analyses restricted to 336 cohorts assessed uniformly with the 5-domain CTQ-instrument showed similar results. Although this 337 study is the largest to date, power to detect an interaction-effect between PRS and CT was still Table S9 ). First, we note that 354 the discovery results are typically based on a discovery sample with an unknown mixture of 355 individuals unexposed (CT=0) and individuals exposed to childhood trauma (CT=1). When assuming 356 qualitative genome-wide interaction with different directions of SNP effects in exposed and 357 unexposed individuals (explaining the same proportion of variance in both groups), the discovery 358 GWAS would mainly tag the effects in unexposed individuals that form the majority of the discovery 359 sample. Consequently, negative interaction between PRS and CT would be detected under this 360 scenario. Second and contrary, for quantitative interaction a positive interaction effect may be 361 expected when SNPs would explain more variance in exposed individuals.
362
To conclude, no overall evidence was found for interaction between PRS and CT. Previously 363 found interaction effects (27, 28) were no longer significant when applying more powerful discovery 364 results. This study provides a cautionary tale for interaction analyses with PRS: it emphasizes the 365 need to meta-analyze results across different cohorts to obtain external validity. The quest 366 continues to clarify the nature of the heterogeneity of MDD, but the present study has shown that 367 the heterogeneity is unlikely to be attributable to moderation of genome-wide genetic effects by CT.
368
Future research may focus on interaction effects between CT and individual SNPs. We hereby call for 369 large GWAS cohorts to assess CT in a uniform manner to facilitate such research in the years the 370 come.
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Legend to Table 1 612 Information is displayed for the cohorts that assessed childhood trauma with the Childhood Trauma 613
Questionnaire (CTQ) covering the 5 domains of sexual abuse, physical abuse, emotional abuse, physical neglect 614 and emotional neglect in a dichotomous 5-domain indicator (exposed versus unexposed) and continuous 615 measure (ranging from 25-125). For the dichotomous CT measure, the proportion of exposed individuals is 616 presented in cases, controls, and in terms of the full population (Pop) assuming a population prevalence of 617 MDD of 15% with twice the prevalence in females (20%) as in males (10%), as well as the odds ratio (OR) of 618 exposed versus unexposed to develop MDD. For the continuous CT measure, the means are displayed in the 619 original scale, and the odds ratio for MDD was assessed for the CTQ measure scaled to variance 1, and can 620 thus be interpreted as increased odds per standard deviation (SD) increase in childhood trauma. The ORs were 621 estimated with logistic regression including sex as covariate. The ORs in the Total sample were estimated with 622 random effect meta-analysis. Legend to Table 2 634
The impact on major depressive disorder (MDD) is displayed for polygenic risk scores (PRS) and their 635 interaction with the 5-domain continuous childhood trauma (CT) measure including sexual abuse, physical 636 abuse, emotional abuse, physical neglect and emotional neglect. The impact of the PRS is presented as the 637 odds ratio (OR) from logistic regression corrected for sex and three principal components, as well as with the 638 variance explained by the PRS on the liability scale. Interaction of PRS with CT (PRSxCT) was assessed as 639 departure from multiplicativity with logistic regression while additionally correcting for the main effects of PRS 640 and CT. Interaction as departure from additivity was expressed as the relative excess risks due to interaction 641 (RERI) estimated as described in the main text, and their 95% confidence intervals (CI) were estimated with 642 bootstrapping with 10,000 iterations. The PRS were based on discovery GWAS results from MDD, 643 schizophrenia (SCZ) and bipolar disorder (BIP). Results in the Total sample were based on random-effect meta-644 analysis of the effects in the individual cohorts. 645 646 Legend to Table 3 M A N U S C R I P T
The impact on major depressive disorder (MDD) is displayed for polygenic risk scores (PRS) and their 648 interaction with the childhood trauma (CT) dichotomous indicator covering sexual abuse and physical abuse 649 (broad definition). The prevalence of CT is presented in MDD cases, controls, and in terms of the full 650 population (Pop) assuming a population prevalence of MDD of 15% with twice the prevalence in females (20%) 651 as in males (10%). The impact of the PRS and CT is presented as the odds ratio (OR) from logistic regression 652 corrected for sex and three principal components, as well as with the variance explained by the PRS on the 653 liability scale. Interaction of PRS with CT (PRSxCT) was assessed as departure from multiplicativity with logistic 654 regression while additionally correcting for the main effects of PRS and CT. The PRS were based on discovery 655 GWAS results from MDD including all SNPs, i.e. with significance threshold p<1. Table 3 . Proportion exposed to childhood trauma (CT) measured as either sexual or physical abuse, and its interaction with polygenic risk scores (PRS with SNP threshold p<1) in predicting major depressive disorder (MDD) Impact on MDD N 
Dichotomous Childhood Trauma Questionnaire (CTQ) score
The CTQ covers the five domains of sexual abuse (SA), physical abuse (PA), emotional abuse (EA), emotional neglect (EN), and physical neglect (PN). Each domain is assessed by five questions (scored 1 to 5) resulting in a domain score ranging from 5 to 25. Per domain, cutoffs were applied to define a narrow definition of childhood trauma separating no or mild trauma from moderate or severe trauma, based on cut-offs for moderate/severe of > 7 (SA), > 9 (PA), > 12 (EA), > 14 (EN), > 9 (PN) respectively. These cut-offs are based on the CTQ manual. From this, an overall dichotomous CTQ indicator was constructed to separate trauma in any of the five domains (1) from trauma in none of the domains (0).
Childhood trauma in DGN and QIMR
In the Depression Gene Network (DGN) cohort, sexual abuse was assessed with two questions:
"Someone touched parts of your body in a sexual way, or had you touch parts of the person in a sexual way"; and "Someone had or attempted to have oral sex, anal sex, or sexual intercourse with you". Physical abuse in DGN was also assessed with two questions: "Someone outside your household physically attacked or assaulted you, threatened you with a weapon or held you captive";
and "Your mother, father or another adult household member hurt you on purpose (for example, beat, choked, kicked, cut or burned you)". The narrow definition was defined as at least one of four questions occurring frequently versus sometimes, rarely or never, and the broad definition as at least one of four questions occurring frequently or sometimes versus rarely or never. For data from the Queensland Institute of Medical Research (QIMR), two instruments were used to assess childhood trauma before the age of 18. Most QIMR individuals were assessed with an instrument covering sexual abuse: touching your sexual parts, you touching their sexual parts, or sexual intercourse (SA assessed with one question for family members and one question for non-family); and physical abuse: being punished by hitting (one question), hurting from punishment next day (one question), being physically injured on purpose (one question). The other QIMR individuals (on the QIMR_3 genotype-batch labeled as M7) were assessed with a questionnaire covering sexual abuse as the occurrence of: exposure to sexual organs, exposure to masturbation, being touched, attempt to have sex, and have sex (SA specified in 16 separate questions); and for physical abuse the occurrence of: being hit, kicked, choked, throttled or locked in by either father, father-figure, mother, or mother-figure (PA specified in 13 separate questions). For QIMR the narrow and broad definitions were defined as above, except for physical abuse from the second questionnaire (QIMR_3_M7) that didn't distinguish between occurring "frequently" and "sometimes" resulting in converging of the narrow and broad definitions. For the analyses, we applied the broad definition. 
Simulation study 1: impact of gene-environment correlation in tests for GxE-interaction
Tests of genotype by environment interaction are known to be scale dependent. In a linear regression model, where a continuous phenotype is regressed on a measured genetic variant (e.g. a candidate gene) and a measured exposure, non-normality of the phenotypic distribution can give rise to spurious interaction effects. We considered this issue given logistic regression of a binary phenotype by means of a small simulation study. We generated phenotypic data based on 12 binary symptoms, which were related to an underlying normally distributed depression liability by a Rasch model (1) . The parameters of the Rasch model were chosen so that the distribution of the sum scores based on the 12 symptoms was highly skewed. We dichotomized the sum score of these 12 symptoms to arrive at the binary phenotype with a prevalence of .20. The underlying normally distributed depression liability was subject to main effects of genes (A; explaining 38.8% of the liability variance) and the main effects of a given exposure (explaining 11.1% is likely to be very low (Table S5) . Simulation study 2
The aim of this simulation study is to aid interpretation of interaction analyses with polygenic risk score (PRS) by simulating different underlying genetic architectures.
Liability threshold model and the impact of childhood trauma (CT) on major depressive disorder (MDD)
Simulation is based on the liability-threshold model, which can be modeled as MDD underpinned by an unobserved liability, ! !"" , where individuals are affected when liability exceeds disease threshold, ! !"" . The liability is assumed to be normally distributed and scaled to a population mean of 0 and variance of 1 (which defines ! !"" given the prevalence of MDD ! !"" ), and to result from independent normally distributed environmental (! !"" ) and genetic effects (! !"" ) with ! !"! =
, the heritability of MDD on the liability scale. Here, we subdivide the environmental effects as ! !"" = !" !"#$"!"%& !"#$% + ! !"#$%&'(,!"! . We assume that !" !"#$%&$' !"#$% is represented by a dichotomous measure that labels individuals as exposed (1) or unexposed (0) with an odd ratio for MDD of exposed of !" !" . For a prevalence of MDD of ! !"" = 0.15 , prevalence of CT of ! !" = 0.25 and !" !" = 3.2 , the !" !"#$%&$' !"#$% can be transformed to !" !"#$"!"%& !"#$% as -0.16 (unexposed) and 0.47 (exposed), and explains 7.4% of variation on the liability scale (Appendix A). Assuming a heritability of MDD of ℎ !,!"" ! = 0.35, the variance explained by the residual environmental effects ! !"#$%&'(,!"" follows as 57.6% (assuming that !" !"#$"!"%& !"#$% , ! !"#$%&'(,!"" , and ! !"" are all independent). For Model 1, we consider CT as part of the environmental effects on MDD, but we note that CT has been found to be heritable itself (2); the consequences of which will be discussed later. In Model 1, we will, further, assume that the genetic and residual environmental effects are equal in those exposed and those unexposed to CT, which can thus be thought of as a "pure additive" model on the liability scale of !" !"#$"!"%& !"#$% , ! !"#$%&'(,!!! , and ! !"" (i.e. no GxE-interaction). After describing simulation of SNP data, we will discuss decreasing the correlation of SNP-effects between those exposed and those unexposed to CT (Model 2), increasing a genetic contribution to CT through introducing a heritability for CT (Model 3), increasing magnitude of SNP-effects on MDD in those exposed compared to those unexposed to CT (Model 4), and decreasing magnitude of residual environmental effects on MDD in those exposed compared to those unexposed to CT (Model 5).
Simulation of SNP data and genetic effects
We simulated individuals in a population one-by-one until a total of 9,000 cases and 9,000 controls were obtained, from which 10,000 were used as discovery and 8,000 as target set. Therefore, we first simulated the SNPs following the method of Golan et al (3) , and subsequently modeled CT and MDD. Briefly, the properties of 10,000 SNPs in full linkage equilibrium were first defined by drawing their minor allele frequencies (MAF) from the uniform distribution from 0.05 to 0.5, and a proportion of 30% of these SNPs were set to have an effect on MDD with effects drawn from a normal distribution with variance ℎ !,!"" ! /3,000 while the effects of the other SNPs were set at 0.
With these SNP effects, an individual ! was simulated by first drawing its allele count (! !" ; 0,1 or 2)
with probabilities of (1 − !"# ! ) ! , 2(1 − !"# ! )!"# ! , and !"# ! ! respectively for all SNP !, and, second, defining its genetic effects as !(!)
Childhood trauma status of individual ! was assigned with probability ! !" , and transformed to the liability scale !"(!) !"#$"!"%& !"#$% as described in Appendix A. The residual environmental effect !(!) !"#$%&'(,!"" was drawn from a normal distribution with variance
, so that the liability of individual ! followed as ! ! = !(!) !"" + !"(!) !"#$"!"%& !"#$% + !(!) !"#$%&'(,!"" . Individual ! was deemed affected with MDD when ! ! > ! !"" and non affected otherwise, where disease threshold ! !"" was defined such that ! !"" = ! ! > ! !"" !~!(0,1)). This procedure was repeated until a total of 9,000 cases and 9,000 controls were obtained. Subsequently, a genome-wide association study (GWAS) was conducted with PLINK on 5,000 cases and 5,000 controls (4), the results of which were used to prepare polygenic risk scores in the target set of the other 4,000 cases and 4,000 controls. For every parameterization, the simulation was repeated 10 times.
Simulation -Model 1
For the base assumption of the genetic architecture we assumed a prevalence of MDD of ! !"" = 0.15, a heritability of MDD of ℎ !,!"" ! = 0.35, a prevalence of CT of ! !" = 0.25, no impact of SNPs in CT (ℎ !,!" ! = 0), and odds ratio for MDD in those exposed to childhood trauma of !" = 3.2, and pure additivity on the liability scale (identical genetic and residual environmental effects in those exposed and those unexposed to childhood trauma).
Simulation -Model 2
A clear case of GxE interaction would be when the individual SNP-effects on MDD in those exposed would differ from the effects in those unexposed, i.e. when ! ! = !"# !""!#$ !"# ! | !"!! , !""!#$ !"# ! | !"!! = 0 for the 3,000 effective SNPs. To model this scenario, we further assumed that the effects are on the same 3,000 SNPs and the variance explained is constant, that is !"# !""!#$ !"# ! | !"!! ) = !"#(!""!#$ !"# ! | !"!! = 0.35. 
Simulation -Model 3
For the Models 1, 2, 4 and 5 we have assumed that CT is purely environmental, but heritability of childhood trauma has been estimated at around 0.5 (2) . Therefore, an impact of SNPs effects on CT is considered here. For this, we assume that CT is a "disease trait" itself with underlying liability as described above for MDD (not suggesting that children are to blame for the trauma they experience, rather we hypothesize that heritability arises from transmitted alleles that affect personality characteristics in parents). Nevertheless, we drew SNP-effects for CT from a random normal distribution with variance ℎ !,!" ! = 0.5 and environmental effects from a normal distribution with variance 1 − ℎ !,!" ! to construct a liability of CT ! !" , and individuals were deemed exposed to CT when ! !" ! > ! !" with the threshold defined such that ! !" = ! ! > ! !" !~!(0,1)). The effects were assigned to the same 3,000 SNPs impacting MDD, but drawn from an independent normal distribution. Given the CT status thus simulated, MDD was derived as described above.
Simulation -Model 4
Another way to think about GxE interaction is that environmental stress might potentiate genetic effects. This was modeled by setting a proportion of genetic effects on MDD in those exposed to those unexposed to CT as !"# !""!#$ !"# ! | !"!! )/!"#(!""!#$ !"# ! | !"!! = 3 while keeping !"# !""!#$ !"# ! | !"!! , !""!#$ !"# ! | !"!! = 1. The variances of SNP-effects where chosen in such way that the variance of genetic effects in the full population were fixed at 0.35, while the residual environmental effects had the same variance in those exposed and those unexposed to CT (Appendix B).
Simulation -Model 5
A hypothetical scenario could be that environmental risk factors for MDD (such as socioeconomic status and life-stress in adulthood) cluster in those exposed to CT; the link between these environmental risk factors would be captured in estimates of the OR of CT, but could in addition result in less residual environmental variation in those exposed compared to those unexposed to childhood trauma. We modeled this as !"# ! !"#$%&'(,!""|!"!! )/!"#(! !"#$%&'(,!""|!"!! = 1/ 3 while assuming constant genetic effects in those exposed and those unexposed to CT,
Appendix A. Transformation of OR to liability scale
To transform the !" from CT on MDD to the liability scale the approach of Witte et al was applied (5) . Therefore, the !" (set at 3.2) was first transformed to the !! (2.6) and consequently to the risk on MDD in exposed (!" = 1 with MDD proportion 0.28) and unexposed (!" = 0 with MDD in proportion 0.11) assuming a population prevalence of ! !"" = 0.15 and ! !" = 0.25. The liability disease threshold for MDD in the full population was found as ! !"",!"## !"!#$%&'"( = Φ !! 1 − ! !"" = Φ !! 1 − 0.15 = 1.0364. First assuming a liability variance of 1 in both exposed and unexposed, the threshold in exposed was found as ! !""|!"!! = ! !! 1 − 0.28 = 0.589 and in unexposed as ! !""|!"!! = Φ !! 1 − 0.11 = 1.241. In line with Witte et al, the mean liability in exposed was found at ! !|!"!! = ! !"",!"## !"!#$%&'"( − ! !""|!"!! and in unexposed at ! !|!"!! = ! !"",!"## !"!#$%&'"( − ! !""|!"!! , allowing to merge exposed and unexposed while ensuring the disease risks of 0.28 and 0.11 respectively. However, because the variance in both exposed and unexposed was assumed to equal 1, the merged sample had a variance larger than 1 introduced by the variance of CT and a mean slightly different from zero. To ease modeling of genetic effects, we rescaled to mean of zero and variance one, also correcting the disease threshold in this manner.
With this, a model was derived transposing CT status of exposed and unexposed to the liability scale, while the overall variance of liability was set at 1, and mean at 0, as usual.
Appendix B. Modeling increased magnitude of SNP-effects in CT=1 compared to CT=0
When aiming to model increased variance of SNP effects in those exposed compared to those unexposed to CT, arbitrary choices have to be made about the residual environmental effects in exposed and unexposed, and the variance of liability, genetic effects and environmental effects in the overall population. We choose to fix the full population variance of liability at 1, variance of genetic effects at ℎ !,!"" ! = 0.35, and variance of environmental effects at 1 − ℎ !,!"" ! = 0.65 (the latter including both the variance of !" !"#$"!"%& as well as residual environmental effects). To obtain e.g. a variance of genetic effects in exposed three times the variance of genetic effects in unexposed !"# !""!#$ !"# ! | !"!! )/!"#(!""!#$ !"# ! | !"!! = 3 , the variance of genetic effects followed as !"# !""!#$ !"# ! | !"!! = 0.56 and !"# !""!#$ !"# ! | !"!! = 0.28 thereby ensuring that the variance of genetic effect in the full population equals !"
0.25 0.56 + 0 ! + 0.75 0.28 + 0 ! − 0 = 035. We choose to fix the residual variance in both exposed and unexposed first at !"#(! !"#$%&'(|!"!! ) = !"#(! !"#$%&'(|!"!! ) = 0.65, and the overall variance of liability was thus larger in exposed than in unexposed. As a result, the sums in Appendix A were slightly adjusted as the variance and mean of the merged sample differed slightly to the above, and therefore correction to obtain variance of 1 and mean of zero in the full population also differed. Table 3 ). However, the potential bias of gene-environment correlation in gene-environment interaction analyses depends on the correlation in the full population. Therefore, cases were randomly sampled such that cases/controls=0.15/0.85 to mimic results in the full population. Sampling was repeated 100 times, and conducted for those cohorts with more than 100 controls only. The Pearson correlation was estimated for the continuous CTQ measure, and the Spearman correlation for the dichotomous CT measure, and analyses were corrected for sex and three principal components. Simulated data of 10,000 SNPs were based on five models, all assuming heritability of MDD of 0.35, prevalence of MDD of 0.15, prevalence of CT of 0.25 and an odds ratio (OR) of CT on MDD of 3.2 (see Supplemental Methods). Model 1: SNP-effects are the same in exposed and unexposed; Model 2: correlation of 0 between SNP-effects in exposed and unexposed; Model 3: SNP-effects on MDD are the same in exposed and unexposed, heritability of CT of 0.5 (for Models 1,2,4, and 5, heritability of CT was set at 0); Models 4: same direction of SNP-effects in exposed and unexposed (correlation of 1), but 3 times larger variance of effects in exposed than unexposed; Model 5: SNPeffects the same in exposed and unexposed, but three times smaller environmental variance in exposed. Simulation was repeated ten times, the means of which are displayed with the standard error (SE) between brackets.
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